Back to regulatory watch
Federal RegisterGuidance and regulationPublished Sep 21, 2026

Chemistry, Manufacturing, and Controls Development and Readiness Pilot Program; Program Announcement

Updated under an hour ago ()

The Food and Drug Administration (FDA or Agency) is announcing year five of the Chemistry, Manufacturing, and Controls (CMC) Development and Readiness Pilot (CDRP). This program facilitates the expedited CMC development of products under an investigational new drug application (IND) based on the anticipated clinical benefit of earlier patient access to the products. FDA has implemented this pilot program to assist with CMC readiness for products regulated by both the Center for Biologics Evaluation and Research (CBER) and the Center for Drug Evaluation and Research (CDER) that have accelerated clinical development timelines. To accelerate CMC development and facilitate CMC readiness, the pilot features increased communication between FDA and sponsors and explores the use of science- and risk-based regulatory approaches, as applicable. This notice outlines the eligibility criteria and process for submitting a request to participate in the pilot.

Tags
health IT, Notice, Health and Human Services Department, Food and Drug Administration
Related exam domains
CISM 2: Information Security Risk Management; CISM 3: Information Security Program
Source record id
2026-19277
First seen by InfoSec Signals
Sep 23, 2026

Source: Federal Register API, Office of the Federal Register, National Archives and Records Administration about this source more from it

Exam domain labels come from a keyword heuristic and are study hints, not an official mapping. The summary is the publisher's own text, shortened; the linked record is authoritative.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.